ESC Premium Access

Cardiac amyloidosis

Event: ESC CONGRESS 2017
Topic: Cardiomyopathies
Session type: Moderated Posters
Date: 29 August 2017
Time: 15:35 - 16:25

Congress Session

7 presentations in this session

Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.

Speaker: Mr M. Nicol (Paris, FR)

Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis


Predictors of progression of light-chain cardiac amyloidosis.

Speaker: Doctor V. Rameev (Moscow, RU)

Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.

Speaker: Professor T. Damy (Creteil, FR)

AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy

Speaker: Associate Professor M. Alhamadsheh (Stockton, US)

Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathy

Speaker: Doctor G. Lima Da Silva (Lisbon, PT)

Different features of cardiac involvement in patients with AL vs. TTR amyloidosis

Speaker: Doctor V. Chubuchny (Pisa, IT)

6 speakers from this session

Mr Martin Nicol

Hospital Lariboisiere, Paris (France)
1 presentation
0 follower

Doctor Vilen Rameev

, Moscow (Russian Federation)
0 follower

Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)
21 presentations
0 follower

Associate Professor Mamoun Alhamadsheh

University of the Pacific, Stockton (United States of America)
0 follower

Doctor Gustavo Lima Da Silva

Hospital De Santa Maria, Lisbon (Portugal)
0 follower

Doctor Vladyslav Chubuchny

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk